| 1 | Study | 1.88% | |
| 2 | New | 1.44% | |
| 3 | Health | 1.33% | |
| 4 | BMC | 1.22% | |
| 5 | Cancer | 1% | |
| 6 | HIV | 0.89% | |
| 7 | Patients | 0.78% | |
| 8 | Africa | 0.67% | |
| 9 | Malaria | 0.67% | |
| 10 | Brain | 0.67% | |
| 11 | Surgery | 0.55% | |
| 12 | Case | 0.55% | |
| 13 | Recurrent | 0.44% | |
| 14 | Aspirin | 0.44% | |
| 15 | Disease | 0.44% | |
| 16 | AllAfrica | 0.44% | |
| 17 | Review | 0.44% | |
| 18 | Against | 0.44% | |
| 19 | Vaccine | 0.44% | |
| 20 | Children | 0.44% | |
| 21 | Liberia | 0.44% | |
| 22 | COVID-19 | 0.44% | |
| 23 | May | 0.44% | |
| 24 | AI | 0.44% | |
| 25 | World | 0.44% | |
| 26 | Tract | 0.33% | |
| 27 | Adverse | 0.33% | |
| 28 | Medical | 0.33% | |
| 29 | Research | 0.33% | |
| 30 | Data | 0.33% | |
| 31 | Risk | 0.33% | |
| 32 | Public | 0.33% | |
| 33 | System | 0.33% | |
| 34 | Therapy | 0.33% | |
| 35 | Giant | 0.33% | |
| 36 | Systematic | 0.33% | |
| 37 | Use | 0.33% | |
| 38 | Technology | 0.33% | |
| 39 | Psychiatry | 0.33% | |
| 40 | Urinary | 0.33% | |
| 41 | Awareness | 0.33% | |
| 42 | Day | 0.22% | |
| 43 | Renal | 0.22% | |
| 44 | Infectious | 0.22% | |
| 45 | Hospital | 0.22% | |
| 46 | COVID | 0.22% | |
| 47 | Fight | 0.22% | |
| 48 | Anti-Malaria | 0.22% | |
| 49 | Meta-Analysis | 0.22% | |
| 50 | Using | 0.22% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
The ASCO Post
2024-04-25 01:40:38
In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer
The ASCO Post
2024-04-25 01:35:36
Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
University of Minnesota Twin Cities
2024-04-25 01:04:20
Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy
AJMC.com Managed Markets Network
2024-04-25 00:00:54
Chiesi survey shows how Fabry drugs are failing patients, providing road map for ousting incumbents
FiercePharma
2024-04-24 23:25:00